A New Perspective on Parkinson’s Disease

My recent medical research has led me to take a closer look at the body’s electrical system, particularly as it relates to neurological disease. One condition of special interest is Parkinson’s disease, which is the second most common neurological disorder in the United States, following Alzheimer’s disease and dementia.

Parkinson’s disease is characterized by a range of symptoms, including tremors, fatigue, shuffling gait, balance difficulties, cognitive decline, constipation, and slowed movement. These symptoms progressively interfere with daily function and quality of life.

The cause of Parkinson’s disease can be genetic or environmental, with exposure to toxins, chemicals, and pesticides thought to play a significant role in many cases. Conventional treatment focuses primarily on physical therapy to address muscle rigidity and medications designed to increase dopamine availability in the brain. Dopamine is a critical neurotransmitter responsible for movement and coordination, and in Parkinson’s patients, dopamine-producing neurons gradually lose function.

While these medications can slow symptom progression, they do not halt the underlying disease process. A major challenge is that many dopamine-based medications have difficulty crossing the blood-brain barrier, requiring increasing doses over time as neuronal function continues to decline. I have patients who must take medication every two hours simply to maintain basic mobility. In cases of severe tremors, some patients undergo implantation of deep brain stimulation devices to help control symptoms. Despite these interventions, the average life expectancy following diagnosis is often cited as 7–15 years.

In searching for more effective approaches, I began reviewing scientific literature examining Parkinson’s disease at the molecular and cellular level. One protein of particular interest is alpha-synuclein, which accumulates at the ends of dopamine-producing nerve cells. Whether due to genetic predisposition or environmental toxicity, this protein can misfold and progressively damage nerve endings. As a result, the affected neurons lose both their ability to produce dopamine and to conduct electrical signals—an essential process for normal brain function.

Encouragingly, emerging research suggests that once this process is better understood, it may be possible to counteract aspects of the damage. Numerous scientific publications describe the potential role of stem cells in supporting nerve repair, rebuilding nerve sheaths, restoring ion channels, and promoting neuronal regeneration. Additional studies indicate that exosomes may help reduce alpha-synuclein accumulation.

In my clinical practice, I have observed notable outcomes using a combination of advanced therapies. One male patient with Parkinson’s disease presented with cognitive decline, fatigue, and significant slowing of movement. After receiving a proprietary application of stem cells and exosomes, he experienced a sustained period of approximately five months without noticeable Parkinson’s symptoms.

A female patient with classic Parkinson’s symptoms—including tremors, balance impairment, severe constipation, fatigue, cognitive decline, and freezing episodes—opted to pursue a different approach. She chose to use an oral medication approved for multiple sclerosis, which is rarely utilized in Parkinson’s care. After 12 weeks, her freezing episodes resolved, balance improved by approximately 90%, memory and voice strength improved, and overall energy increased.

Another patient, an elderly gentleman diagnosed with Parkinson’s disease and Lewy Body Dementia—a condition characterized by extensive alpha-synuclein accumulation and typically associated with a 3–5 year life expectancy—presented with profound cognitive instability and severely slowed movement. He was treated with stem cells, exosomes, and the same oral medication. Twelve weeks later, he demonstrated marked improvement in alertness, memory, and functional ability.

By examining Parkinson’s disease from a broader biological and electrical perspective, and tailoring treatment accordingly, it may be possible to help patients reclaim aspects of their health and quality of life. While continued research is essential, these early results are encouraging and support the pursuit of innovative, individualized approaches to care.

– John Young, M.D.

727-545-4600 YoungFoundationalHealth.com